Australian researchers are leading the world in the battle to eliminate hepatitis C.
It is estimated nearly half of the more than 213,000 Australians living with the virus remain undiagnosed and only around five per cent are currently receiving treatment. Photo: Shutterstock.
Australia is on track to eliminate hepatitis C if record numbers of people living with the virus continue to seek and receive breakthrough antiviral treatment, according to a new analysis.
Rates of blood-borne viruses such as hepatitis are disproportionately high among Indigenous people. Photo:istock
An Indigenous hepatitis project in Western Sydney could be expanded across NSW, thanks to input from UNSW health researchers.
Between 80 and 130 million people worldwide are infected with Hepatitis C (Shutterstock).
Australian funding of new hepatitis C treatments has provided the therapeutic tools to eliminate the disease as a public health issue within a decade, writes Greg Dore.
A world-first Kirby Institute study has found opiate substitution therapy can protect against the hepatitis C (HCV) virus (Ramin Talaie).
Up to two million hepatitis C infections could be averted worldwide in the next ten years if opioid substitution therapy was more readily available to injecting drug users, a study from UNSW’s Kirby Institute has found.